[ Price : $8.95]
FDA grants fast track designation to an investigative Kyverna CAR-T drug to treat some patients with multiple sclerosis.[ Price : $8.95]
FDA warns Mexicos Glicerinas Industriales about CGMP deviations in its manufacturing of active pharmaceutical ingredients.[ Price : $8.95]
Autolus Therapeutics says FDA has accepted for review its BLA for obecabtagene autoleucel as a potential treatment for relapsed/re...[ Price : $8.95]
FDA approves a Vanda Pharmaceuticals IND to evaluate VCA-894A for treating patients with Charcot-Marie-Tooth disease, axonal, Type...[ Price : $8.95]
FDA orders safety labeling changes for five CAR-T immunotherapies after investigating an identified risk of T-cell malignancy foll...[ Price : $8.95]
The U.S. Court of Federal Claims says one part of a Vanda claim against FDA involving the agencys actions in reviewing generic dru...[ Price : $8.95]
A StatNews column calls for FDA and FTC collaboration to regulate social media videos and comments from influencers on prescriptio...[ Price : $8.95]
FDA publishes a draft guidance on characterizing metallic or calcium phosphate coatings on Class 2 and 3 orthopedic medical device...